Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1954 3
1956 1
1959 1
1960 2
1961 1
1962 1
1965 1
1969 2
1971 2
1972 1
1973 1
1975 2
1977 5
1978 3
1980 2
1982 1
1990 3
1991 8
1992 4
1993 3
1994 1
1995 4
1996 5
1997 3
1998 5
1999 3
2000 2
2001 13
2002 14
2003 23
2004 35
2005 33
2006 28
2007 43
2008 38
2009 35
2010 31
2011 29
2012 23
2013 23
2014 23
2015 27
2016 40
2017 22
2018 26
2019 29
2020 46
2021 46
2022 34
2023 41
2024 26
2025 28

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

765 results

Results by year

Filters applied: . Clear all
Page 1
Melissa Paoloni.
[No authors listed] [No authors listed] Nat Rev Drug Discov. 2016 Aug 30;15(9):598. doi: 10.1038/nrd.2016.174. Nat Rev Drug Discov. 2016. PMID: 27573228 No abstract available.
Clinical definition of sarcopenia.
Santilli V, Bernetti A, Mangone M, Paoloni M. Santilli V, et al. Clin Cases Miner Bone Metab. 2014 Sep;11(3):177-80. Clin Cases Miner Bone Metab. 2014. PMID: 25568649 Free PMC article. Review.
Maxillary arch development with Invisalign system.
Lione R, Paoloni V, Bartolommei L, Gazzani F, Meuli S, Pavoni C, Cozza P. Lione R, et al. Angle Orthod. 2021 Jul 1;91(4):433-440. doi: 10.2319/080520-687.1. Angle Orthod. 2021. PMID: 33570617 Free PMC article.
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial.
Platzbecker U, Avvisati G, Cicconi L, Thiede C, Paoloni F, Vignetti M, Ferrara F, Divona M, Albano F, Efficace F, Fazi P, Sborgia M, Di Bona E, Breccia M, Borlenghi E, Cairoli R, Rambaldi A, Melillo L, La Nasa G, Fiedler W, Brossart P, Hertenstein B, Salih HR, Wattad M, Lübbert M, Brandts CH, Hänel M, Röllig C, Schmitz N, Link H, Frairia C, Pogliani EM, Fozza C, D'Arco AM, Di Renzo N, Cortelezzi A, Fabbiano F, Döhner K, Ganser A, Döhner H, Amadori S, Mandelli F, Ehninger G, Schlenk RF, Lo-Coco F. Platzbecker U, et al. J Clin Oncol. 2017 Feb 20;35(6):605-612. doi: 10.1200/JCO.2016.67.1982. Epub 2016 Oct 31. J Clin Oncol. 2017. PMID: 27400939 Free article. Clinical Trial.
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial.
Bassan R, Chiaretti S, Della Starza I, Spinelli O, Santoro A, Paoloni F, Messina M, Elia L, De Propris MS, Scattolin AM, Audisio E, Marbello L, Borlenghi E, Zappasodi P, Mauro E, Martinelli G, Mattei D, Fracchiolla N, Bocchia M, De Fabritiis P, Bonifacio M, Candoni A, Cassibba V, Di Bartolomeo P, Latte G, Trappolini S, Guarini A, Vitale A, Fazi P, Piciocchi A, Rambaldi A, Foà R. Bassan R, et al. Blood Adv. 2023 Aug 22;7(16):4448-4461. doi: 10.1182/bloodadvances.2022009596. Blood Adv. 2023. PMID: 37276451 Free PMC article.
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Foà R, Vitale A, Vignetti M, Meloni G, Guarini A, De Propris MS, Elia L, Paoloni F, Fazi P, Cimino G, Nobile F, Ferrara F, Castagnola C, Sica S, Leoni P, Zuffa E, Fozza C, Luppi M, Candoni A, Iacobucci I, Soverini S, Mandelli F, Martinelli G, Baccarani M; GIMEMA Acute Leukemia Working Party. Foà R, et al. Blood. 2011 Dec 15;118(25):6521-8. doi: 10.1182/blood-2011-05-351403. Epub 2011 Sep 19. Blood. 2011. PMID: 21931113 Free article. Clinical Trial.
DNA methyltransferase 3A (DNMT3A) mutations and PD-(L)1 blockade efficacy in non-small-cell lung cancer.
Ricciuti B, Scalera S, Wang X, Elkrief A, Tagliamento M, Gariazzo E, Paoloni F, Miller PG, Pecci F, Di Federico A, Santo V, Alessi JV, Aldea M, Garbo E, Lamberti G, Zrafi W, Micol JB, Sholl LM, Nishino M, Cappuzzo F, Calonaci N, Caravagna G, Ferrara R, Besse B, Schoenfeld A, Maugeri-Sacca M, Awad MM. Ricciuti B, et al. Ann Oncol. 2025 Oct;36(10):1132-1141. doi: 10.1016/j.annonc.2025.06.003. Epub 2025 Jun 18. Ann Oncol. 2025. PMID: 40541864
765 results